<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>BIOCORRX RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Mon, 28 Sep 2026 07:40:24 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/aktien/biocorrx%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>BIOCORRX RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>EQS-News: BioCorRx Inc. Appoints Former Acting White House Drug Policy Director Richard J. Baum to Strategic Advisory Board</title><pubDate>Thu, 10 Sep 2026 11:16:21 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biocorrx-inc-appoints-former-acting-white-house-drug-policy-director-richard-j-baum-to-strategic-advisory-board-15927458</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/biocorrx-aktie">BioCorRx</a> Inc


 / Key word(s): Manufacturing


<br/>


BioCorRx Inc. Appoints Former Acting White House Drug Policy Director Richard  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biocorrx-inc-appoints-former-acting-white-house-drug-policy-director-richard-j-baum-to-strategic-advisory-board-15927458</guid></item><item><title>EQS-News: BioCorRx Announces National Drug Codes (NDCs) for LUCEMYRA (lofexidine) Brand and Authorized Generic (AG) SKUs to Ensure Uninterrupted Market Supply</title><pubDate>Tue, 25 Aug 2026 14:20:11 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-biocorrx-announces-national-drug-codes-ndcs-for-lucemyra-lofexidine-brand-and-authorized-generic-ag-skus-to-ensure-uninterrupted-market-supply-15899112</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: <a href="https://www.finanzen.net/aktien/biocorrx-aktie">BioCorRx</a> Inc


 / Key word(s): Financial


<br/>


BioCorRx Announces National Drug Codes (NDCs) for LUCEMYRA (lofexidine) Brand and  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-biocorrx-announces-national-drug-codes-ndcs-for-lucemyra-lofexidine-brand-and-authorized-generic-ag-skus-to-ensure-uninterrupted-market-supply-15899112</guid></item><item><title>EQS-News: BioElectronics Corporation Doubles Facility Space to Support Electrome's Commercial  ActiPatch Launch and Anticipated Sales Growth</title><pubDate>Tue, 21 Jul 2026 14:21:11 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-bioelectronics-corporation-doubles-facility-space-to-support-electrome-s-commercial-actipatch-launch-and-anticipated-sales-growth-15810898</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: BioElectronics Corporation


 / Key word(s): Financial


<br/>


BioElectronics Corporation Doubles Facility Space to Support Electrome's Commercial  ActiPatch Launch and  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-bioelectronics-corporation-doubles-facility-space-to-support-electrome-s-commercial-actipatch-launch-and-anticipated-sales-growth-15810898</guid></item><item><title>EQS-News: BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress</title><pubDate>Tue, 30 Jun 2026 14:20:01 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-bioelectronics-issues-chairman-s-update-highlighting-sales-growth-and-strategic-progress-15772826</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: BioElectronics Corporation


 / Key word(s): Financial


<br/>


BioElectronics Issues Chairman's Update Highlighting Sales Growth, and Strategic Progress <br/><br/>30.06.2026  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-bioelectronics-issues-chairman-s-update-highlighting-sales-growth-and-strategic-progress-15772826</guid></item><item><title>EQS-News: BioElectronics Advances ActiPatch Commercial Rollout With Electrome</title><pubDate>Wed, 17 Jun 2026 16:20:21 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-bioelectronics-advances-actipatch-commercial-rollout-with-electrome-15750296</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: BioElectronics Corporation


 / Key word(s): Healthcare


<br/>


BioElectronics Advances ActiPatch Commercial Rollout With Electrome <br/><br/>17.06.2026 / 16:20 CET/CEST<br/>



The  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-bioelectronics-advances-actipatch-commercial-rollout-with-electrome-15750296</guid></item><item><title>EQS-News: ActiPatch Expands to Taiwan, Challenging Traditional Pain Management With Drug-Free Innovation</title><pubDate>Wed, 22 Apr 2026 14:23:31 +0200</pubDate><link>https://www.finanzen.net/nachricht/aktien/eqs-news-actipatch-expands-to-taiwan-challenging-traditional-pain-management-with-drug-free-innovation-15626805</link><description><![CDATA[<p>



	






<table border="0" cellpadding="0" cellspacing="0"><tr><td>


EQS-News: BioElectronics Corporation


 / Key word(s): Financial


<br/>


ActiPatch Expands to Taiwan, Challenging Traditional Pain Management With Drug-Free Innovation <br/><br/>22.04.2026  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/eqs-news-actipatch-expands-to-taiwan-challenging-traditional-pain-management-with-drug-free-innovation-15626805</guid></item></channel></rss>
